J Korean Ophthalmol Soc.  1995 Apr;36(4):643-649.

Retinotoxicity of Intravitreal Mitomycin C

Affiliations
  • 1Department of Ophthalmology, School of Medicine, Kyungpook National University, Taegu, Korea.

Abstract

Mitomycin C(MMC), an antineoplastic drug, is a potent inhibitor of cell mitosis, and the intravitreal application of MMC can be a useful treatment for proliferative vitreoretinopathy by inhibiting intraocular cellular proliferation. We investigated the retinal toxicity of an intravitreal injection of MMC in the pigmented rabbits electroretinographically and histologically. Pigmented rabbits received various dosages of intravitreal MMC(1.0, 2.0, 3.0, 4.0, 10.0 microgram) at a constant volume of 0.1ml. Eltroretinographic data were obtained on 1, 3, 5, 7, days after injection and compared with preinjection ERG data. On 14 days after injection, we evaluated the retinel toxicity of MMC histologically. A dosage of 1.0 microgram MMC resulted in no demonstrable retinal toxicity by electroretinographical and histological studies. A toxic dose of MMC(2.0, 3.0, 4.0, 10.0 microgram) suppressed the b-wave and that of oscillatory potentials were not affected. This fact may suggest that a toxic dose of intravitreal MMC have caused destructive retinopathy. On the light microscopic examination, the outer layer of the retina was most sensitive to the toxic effect of MMC, and higher than 2.0 microgram dosage of MMC affected all layers of the retina.

Keyword

Electroretinogram; Intravitreal injection; Mitomycin C; Retinotoxicity

MeSH Terms

Cell Proliferation
Intravitreal Injections
Mitomycin*
Mitosis
Rabbits
Retina
Retinaldehyde
Vitreoretinopathy, Proliferative
Mitomycin
Retinaldehyde
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr